Evidence map›Paper›PMID 20188532›Full record

ReviewProstaglandins, leukotrienes, and essential fatty acids

n-3 polyunsaturated fatty acids--physiological relevance of dose.

Wooki Kim, David N McMurray, Robert S Chapkin

Open access · greenAbstract readReview
In one paragraph

Review in Prostaglandins, leukotrienes, and essential fatty acids. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Relevance of Fatty Acids to Sperm Maturation and Quality.Oxidative medicine and cellular longevity · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wooki KimProgram in Integrative Nutrition & Complex Diseases, Texas A&M University, College Station, TX 77843, USA.
David N McMurray
Robert S Chapkin
Texas A&M University · USTexas A&M Health Science Center · US

Funding

Pilot--Health Science ResearchP30ES009106 · NIEHS · TEXAS A&M UNIVERSITY SYSTEM · PI SAFE, STEPHEN H. · 1998 to 2006
$9.2M
Colonic Cytokinetics and Cell Signaling: Dietary EffectsR01CA059034 · NCI · TEXAS A&M UNIVERSITY SYSTEM · PI CHAPKIN, ROBERT STEPHEN · 1995 to 2012
$3.6M
N-3 Fatty Acids Alter T Cell Activation and SignalingR01DK071707 · NIDDK · TEXAS A&M UNIVERSITY · PI CHAPKIN, ROBERT STEPHEN · 2007 to 2011
$1.5M
NCI NIH HHS CA59034NCI NIH HHS R01 CA059034NIDDK NIH HHS DK071707NIDDK NIH HHS R01 DK071707NIEHS NIH HHS P30 ES009106NIEHS NIH HHS P30ES09106
6 · The paper itself

Abstract

n-3 polyunsaturated fatty acids (PUFA) are widely used for chemotheraphy/chemoprevention of chronic diseases. However, the molecular mechanism(s) by which the bioactive n-3 PUFA (eicosapentaenoic acid and docosahexaenoic acid) modulate effector pathways are not fully elucidated. Multiple experimental approaches, including use of animal models, cell lines, and human clinical trials, have been utilized to dissect the complex effectors. It is imperative to link these different experimental approaches together in order to interpret outcomes in the context of human physiology and pathophysiology. Unfortunately, the adoption of a broad array of model systems and a wide range of fatty acid exposures (i.e. doses) has made it difficult to interpret biological outcomes. Therefore, in this mini-review we discuss the impact of (a) molecular structure of bioactive fatty acids, (b) dose relevance relative to human consumption, (c) enrichment of fatty acids in sera and tissues following dietary intake, and (d) limitations of cell/tissue culture studies.

Indexed as

AnimalsBiological AvailabilityDietary FatsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3HumansNutritional RequirementsTissue DistributionDietary FatsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3

Identifiers

PMID20188532
PMCPMC2875929
OpenAlexW1987659666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.